Abstract
Background
Abnormalities in the electrocardiographic QT interval duration have been associated with an increased risk of ventricular arrhythmias and sudden cardiac death. However, there is substantial uncertainty about the effect of modifiable factors such as coffee intake, cigarette smoking, alcohol consumption, and physical activity on QT interval duration.
Methods
We studied 7795 men and women from the Third National Health and Nutrition Survey (NHANES III, 1988–1994). Baseline QT interval was measured from the standard 12-lead electrocardiogram. Coffee and tea intake, alcohol consumption, leisure-time physical activities over the past month, and lifetime smoking habits were determined using validated questionnaires during the home interview.
Results
In the fully adjusted model, the average differences in QT interval comparing participants drinking ≥6 cups/day to those who did not drink any were −1.2 ms (95% CI −4.4 to 2.0) for coffee, and −2.0 ms (−11.2 to 7.3) for tea, respectively. The average differences in QT interval duration comparing current to never smokers was 1.2 ms (−0.6 to 2.9) while the average difference in QT interval duration comparing participants drinking ≥7 drinks/week to non-drinkers was 1.8 ms (−0.5 to 4.0). The age, race/ethnicity, and RR-interval adjusted differences in average QT interval duration comparing men with binge drinking episodes to non-drinkers or drinkers without binge drinking were 2.8 ms (0.4 to 5.3) and 4.0 ms (1.6 to 6.4), respectively. The corresponding differences in women were 1.1 (−2.9 to 5.2) and 1.7 ms (−2.3 to 5.7). Finally, the average differences in QT interval comparing the highest vs. the lowest categories of total physical activity was −0.8 ms (−3.0 to 1.4).
Conclusion
Binge drinking was associated with longer QT interval in men but not in women. QT interval duration was not associated with other modifiable factors including coffee and tea intake, smoking, and physical activity.
Introduction
Extremely abnormal prolongation or reduction of the electrocardiographic QT interval duration, such as seen in individuals with Mendelian forms of long or short QT syndromes, is associated with increased risk of ventricular arrhythmias and sudden cardiac death [1]–[5]. Furthermore, population studies have also shown associations between smaller increases in QT interval duration and total mortality, cardiovascular mortality, and sudden cardiac death [6]–[17].
Besides genetic disorders and pharmacologic agents that can cause marked prolongation or shortening of the QT interval [18], other factors associated with less extreme QT interval variability in the general population include age, sex, hypertension, body mass index, low-calorie diets, electrolytes [19]–[20], and common genetic variants [21]. However, there is substantial uncertainty about the association of modifiable factors, such as coffee intake, cigarette smoking, alcohol consumption, and physical activity with QT interval duration [22]–[34]. Although several studies have assessed the effect of individual risk factors on QT interval, many of them were small and/or based on selected samples, resulting in inconsistent findings. The purpose of this analysis was thus to investigate the association of coffee, tea, or alcohol intake, smoking, and physical activity with QT interval duration in a large representative sample of the general US population.
The NHANES III study was conducted by the National Center for Health Statistics (NCHS) of the Centers for Disease Control and Prevention (CDC). It is a national survey that collects extensive health information of the general US population from both interviews and medical examinations. The NHANES III study was approved by the NCHS Research Ethics Review Board (ERB), and documented consent was obtained from participants.
Methods
Study Population
We analyzed data from the Third National Health and Nutrition Examination Survey (NHANES III), a cross-sectional study conducted between 1988 and 1994 that used a multistage stratified clustered probability design to select a representative sample of the civilian non-institutionalized US population [35]. The present study was restricted to participants 40 years of age and older as 12-lead electrocardiograms (ECGs) were only performed in this age group. Of the 8,561 participants 40 years of age or older who had available ECG measurements, we excluded 194 participants with missing QT interval duration or heart rate, 535 participants with QRS ≥120 ms, and 37 participants with missing data on coffee, tea, or alcohol intake, smoking, or physical activity. The final analysis was based on 7,795 participants (3,682 men and 4,113 women).
Data collection
NHANES III included a standardized questionnaire administered in the home by a trained interviewer and a detailed physical examination at a mobile examination center. Demographics, education, medical history, and medication use were assessed by interview. QT-prolonging medications were defined according to the Arizona Center for Education and Research on Therapeutics database [36]. Height and weight were measured and body mass index was calculated as weight in kilograms divided by height in meters squared. Blood pressure was measured three times during the in-home interview and three additional times during the participant’s visit to the mobile examination center. Laboratory tests included total cholesterol, HDL cholesterol, plasma glucose, serum potassium, and serum calcium. Diabetes was defined as a fasting plasma glucose ≥126 mg/dL, a nonfasting plasma glucose ≥200 mg/dL, and/or current use of oral hypoglycemic agents or insulin.
Exposure assessment
Coffee and tea consumption over the past month were determined using a food frequency questionnaire during the home interview [35]. The questionnaire asked how often the participants had regular coffee or tea per month, and we categorized the responses into 0, <1, 1–3, 4–5, and ≥6 cups/day. Based on the U.S. Department of Agriculture food composition sources, we estimated that the caffeine of a cup of coffee or tea were 137 and 47 mg, respectively [37]–[38], and used the frequency of coffee and tea consumption to estimate caffeine intake. In NHANES III, regular colas and sodas were coded together in one variable. Since not all sodas contain caffeine, we did not include colas when calculating total caffeine intake in the main analyses, but performed sensitivity analyses including the contribution of regular colas and sodas to caffeine, assuming that one drink contained 46 mg of caffeine. Caffeine intake was categorized into quartiles in the analysis.
Participants were asked if they had smoked more than 100 cigarettes in their lifetime and if they were current smokers during the home interview. In addition, serum cotinine, a valid and reliable biomarker of exposure to tobacco smoke, was analyzed using high performance liquid chromatography/atmospheric-pressure ionization tandem mass spectrometry [39]. In the present analysis, current smokers were defined as those who self-reported as current smokers, or those who had serum cotinine >10 ng/ml [40]. Former smokers were those participants who had smoked more than 100 cigarettes but were not current smokers. Participants who had not smoked more than 100 cigarettes in their lifetime and had serum cotinine <10 ng/ml were considered never smokers. Current smokers were further categorized into quartiles based on pack-years smoked (a pack-year defined as 20 cigarettes/day for 1 year), and serum cotinine concentrations [41]. In addition, never smokers who were exposed to second-hand smoke (SHS exposed never smokers) were further separated from never smokers who were not exposed to passive smoking (SHS unexposed never smokers). Since the detection limit of continine in NHANES III was 0.05 ng/ml, SHS unexposed never smokers were defined as never smokers with cotinine level <0.05 ng/ml, while SHS exposed nonsmoker were defined as never smokers with cotinine level between 0.05 and 10 ng/ml [42].
Alcohol consumption was also assessed by the food frequency questionnaire. Participants reported the number of times that they drank beer, wine, and hard liquor in the past month and we categorized total alcohol consumption into 4 groups (0, 1–3, 4–6, ≥7 drinks/week). In addition, the frequency of heavy episodic drinking was assessed during the alcohol and drug component of the examination. Participants were classified as binge drinkers if they had at least five alcoholic drinks in a single day during the past 12 months.
Leisure-time physical activity in the past month was ascertained during the home interview. Physical activities were coded and classified according to the rate of energy expenditure using a standardized scheme [43]. Moderate physical activities included walking, biking, swimming, aerobics, dancing, calisthenics, gardening, lifting weights, and other physical activities if they met age-specific cut-offs of metabolic equivalents (METs): ≥3.0 METs for ages 20–39 years; ≥2.5 METs for ages 40–64 years; ≥2.0 METs for ages 65–79 years; and ≥1.26 METs for age 80 years or older. Vigorous physical activity included jogging or running. In addition, swimming and aerobics were classified as vigorous for participants 40 years or older; biking, dancing, gardening, and calisthenics were classified as vigorous for participants 65 years or older; and walking and lifting weights were classified as vigorous for participants 80 years and older. Other physical activities were also considered vigorous if they met age-specific MET cut-offs: ≥7.2 METs for ages 20–39 years, ≥6.0 METs for ages 40–64 years, ≥4.8 METs for ages 65–79 years, and ≥3.0 METs for age 80 years and older [41]. Total (moderate or vigorous) physical activity was categorized into 0, <3, 3–7.9, and ≥8 times/week. Vigorous physical activity was categorized into 0, <1, 1–4, and >4 times/week.
QT interval
Standard 12-lead resting ECG recordings were performed using a Marquette MAC 12 electrocardiograph (Marquette Medical Systems, Inc., Milwaukee, WI, USA) with signals sampled at 250 samples per second per channel. A representative P-QRS-T cycle was then derived by selective averaging using the Dalhousie ECG Analysis Program [44]. Resting heart rates and QT intervals were obtained from the ECGs. All ECGs were read centrally at the Epidemiological Cardiology Research Center, EPICARE (Wake Forest University, Winston-Salem, NC).
Statistical Analysis
The ECG sampling weights were used in the analysis to account for the complex sampling design [35]. The primary effect measure was the adjusted difference and 95% confidence interval (CI) in QT interval duration by categories of each exposure compared to the reference category, calculated from multivariable linear regression models. We used four models with progressive degrees of adjustment. First, we adjusted for age (continuous), race-ethnicity (non-Hispanic white, non-Hispanic black, Mexican-American, other), sex, and RR-interval (restricted quadratic splines with knots at the 5th, 50th, and 95th percentiles). Second, we further adjusted for BMI (continuous), high school education (yes, no), annual household income (<$20,000, ≥$20,000), and use of QT-prolonging medications (yes, no). Third, we further adjusted for systolic blood pressure, blood pressure lowering medication, total and HDL cholesterol, diabetes, history of myocardial infarction, history of congestive heart failure, serum potassium (continuous), and serum calcium (continuous). Finally, fully adjusted models further included all exposures of interest (i.e., coffee, tea, and alcohol intake, smoking, and physical activity) in a single model. Tests for linear trend across categories of each exposure were computed by including a variable with the median value for each category of exposure in the linear regression models.
Seconday analyses included stratified analysis by sex (as women tend to have longer QT intervals than men), and sensitivity analysis using Bazett’s corrected QT interval as the outcome (Table S1; results were similar to the main analysis). All statistical analyses were conducted using SUDAAN (version 10.0; Research Triangle Institute, Research Triangle Park, NC).
Results
The average age of study participants was 56.5 years, and 45.1% of them were male (Table 1). Non-Hispanic whites comprised 80.7% of the study population. The average duration of the QT interval was 406.3 ms.
Table 1. Baseline characteristics.
| Characteristic | NHANES III (N = 7,795) |
| Age (years) a | 56.5 (0.4) |
| Male | 45.1 |
| Race/ethnicity | |
| White | 80.7 |
| Black | 9.0 |
| Other | 10.4 |
| High school education | 70.8 |
| Low family income | 30.9 |
| Use of QT prolonging medication | 12.0 |
| Diabetes | 8.6 |
| Myocardial infarction | 5.2 |
| Hypertension | 36.7 |
| Total cholesterol (mg/dL) | 218.0 (0.9) |
| HDL (mg/dL) | 51.0 (0.4) |
| BMI (kg/m2) | 27.3 (0.1) |
| Heart rate (beat/min) | 68.1 (0.2) |
| QT interval (ms) | 406.3 (0.6) |
Values are means (SE) or percentages unless otherwise noted.
In the fully adjusted model, the average differences in QT interval comparing participants drinking ≥6 cups/day to those who did not drink any were −1.2 (95% CI −4.4 to 2.0) for coffee, and −2.0 ms (−11.2 to 7.3) for tea, respectively (Table 2). The average difference in QT interval comparing the highest vs. the lowest quartiles of caffeine intake was −1.2 ms (−2.7 to 0.3). With respect to smoking, the average differences in QT interval duration comparing current and former smokers to never smokers in fully adjusted models were 1.2 ms (−0.6 to 2.9) and 0.4 ms (−0.9, 1.7), respectively (Table 3). Among smokers, the average difference in QT interval comparing the highest vs. the lowest quartiles of pack-years was 2.6 ms (−1.0 to 6.2), while the average difference comparing highest vs. the lowest quartiles of serum cotinine concentrations was 1.5 ms (−2.1 to 5.2). SHS exposed never smokers had similar QT interval durations as SHS unexposed never smokers.
Table 2. Adjusted difference (95%CI) in QT interval duration by categories of coffee, tea, and caffeine intake.
| N | Mean QT | Model 1 a | Model 2 b | Model 3 c | Model 4 d | |
| Coffee (cups/day) | ||||||
| 0 | 2347 | 406.8 (404.8, 408.9) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) |
| <1 | 3671 | 406.7 (405.2, 408.3) | −0.7 (−2.0, 0.5) | −0.8 (−2.1, 0.5) | −0.7 (−1.9, 0.5) | −0.9 (−2.2, 0.4) |
| 1–3 | 1257 | 405.0 (402.7, 407.4) | −1.8 (−3.2, −0.3) | −1.5 (−3.0, 0.0) | −1.2 (−2.7, 0.3) | −1.6 (−3.2, 0.1) |
| 4–5 | 311 | 402.0 (399.0, 405.1) | −0.2 (−2.7, 2.3) | 0.5 (−1.9, 3.0) | 1.1 (−1.3, 3.5) | 0.6 (−2.0, 3.2) |
| ≥6 | 209 | 404.7 (400.1, 409.2) | −1.1 (−4.3, 2.2) | −1.1 (−4.5, 2.4) | −0.7 (−4.1, 2.8) | −1.2 (−4.4, 2.0) |
| p-trend | 0.03 | 0.42 | 0.61 | 0.89 | 0.59 | |
| Tea (cups/day) | ||||||
| 0 | 4137 | 407.2 (405.6, 408.7) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) |
| <1 | 3242 | 405.3 (403.8, 406.8) | −0.4 (−1.5, 0.8) | −0.4 (−1.6, 0.7) | −0.2 (−1.4, 1.0) | −0.1 (−1.4, 1.1) |
| 1–3 | 343 | 403.4 (398.0, 408.8) | −1.8 (−4.5, 1.0) | −2.3 (−5.1, 0.5) | −2.4 (−5.4, 0.5) | −2.4 (−5.3, 0.6) |
| 4–5 | 58 | 403.8 (393.3, 414.3) | −0.1 (−4.9, 4.7) | −0.8 (−5.2, 3.6) | 0.8 (−4.2, 5.8) | 0.6 (−4.3, 5.6) |
| ≥6 | 15 | 405.9 (393.7, 418.2) | 0.3 (−9.1, 9.7) | 1.2 (−8.4, 10.7) | −2.1 (−11.4, 7.2) | −2.0 (−11.2, 7.3) |
| p-trend | 0.18 | 0.44 | 0.33 | 0.27 | 0.27 | |
| Caffeine (mg/day) | ||||||
| <24.2 | 2080 | 408.4 (406.3, 410.4) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) |
| 24.2–135.2 | 2425 | 405.8 (404.2, 407.4) | −1.6 (−3.0, −0.1) | −1.6 (−3.1, −0.2) | −1.1 (−2.6, 0.4) | −1.3 (−2.8, 0.3) |
| 135.2–274.9 | 1489 | 406.6 (404.0, 409.3) | −0.1 (−1.4, 1.3) | −0.1 (−1.6, 1.3) | 0.1 (−1.4, 1.6) | −0.1 (−1.6, 1.5) |
| ≥274.9 | 1801 | 404.2 (402.5, 405.8) | −1.6 (−2.9, −0.2) | −1.3 (−2.7, 0.1) | −0.8 (−2.2, 0.6) | −1.2 (−2.7, 0.3) |
| p-trend | <0.001 | 0.05 | 0.13 | 0.35 | 0.17 |
a. Adjusted for age (continuous), race-ethnicity (non-Hispanic white, non-Hispanic black, Mexican-American, other), sex, and RR-interval (restricted quadratic splines with knots at the 5th, 50th, and 95th percentiles).
b. Further adjusted for BMI (continuous), high school education (yes, no), annual household income (<$20,000, ≥$20,000), and use of QT-prolonging medications (yes, no).
c. Further adjusted for systolic blood pressure, blood pressure lowering medication, total and HDL cholesterol, diabetes, history of myocardial infarction, history of congestive heart failure, serum potassium (continuous), and serum calcium (continuous).
d. Further adjusted for smoking (current, former, never), number of drinks (continuous), and total physical activity (continuous).
Table 3. Adjusted difference (95%CI) in QT interval duration by categories of smoking, pack-years, and serum cotinine.
| N | Mean QT | Model 1 a | Model 2 b | Model 3 c | Model 4 d | |
| Smoking | ||||||
| Never | 3306 | 407.8 (406.2, 409.4) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) |
| Former | 2247 | 407.6 (405.7, 409.6) | 0.5 (−0.9, 1.9) | 0.4 (−1.0, 1.8) | 0.4 (−0.9, 1.7) | 0.4 (−0.9, 1.7) |
| Current | 2242 | 402.1 (400.0, 404.3) | 0.7 (−1.0, 2.4) | 0.9 (−0.9, 2.6) | 1.2 (−0.5, 2.9) | 1.2 (−0.6, 2.9) |
| p-value (former vs. never) | 0.90 | 0.49 | 0.56 | 0.54 | 0.57 | |
| p-value (current vs. never) | <0.001 | 0.45 | 0.34 | 0.16 | 0.20 | |
| Pack-years (current smokers only) | ||||||
| ≤14.9 | 697 | 405.3 (402.2, 408.3) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) |
| 14.9–31.4 | 588 | 400.9 (396.9, 404.8) | 0.5 (−2.6, 3.6) | 0.2 (−3.0, 3.3) | 0.4 (−2.7, 3.5) | 0.3 (−2.8, 3.4) |
| 31.4–49.7 | 447 | 400.0 (395.5, 404.5) | 0.7 (−2.2, 3.7) | 0.9 (−2.1, 3.9) | 0.8 (−2.6, 4.2) | 0.7 (−2.8, 4.1) |
| ≥49.7 | 437 | 402.0 (397.8, 406.3) | 3.1 (0.0, 6.2) | 3.0 (−0.2, 6.1) | 2.8 (−0.7, 6.3) | 2.6 (−1.0, 6.2) |
| p-trend | 0.23 | 0.04 | 0.05 | 0.11 | 0.15 | |
| Serum cotinine (ng/ml, current smokers only) | ||||||
| <127.7 | 623 | 406.0 (403.1, 408.9) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) |
| 127.7–226.8 | 493 | 404.3 (399.1, 409.6) | 2.4 (−0.8, 5.6) | 2.5 (−0.8, 5.8) | 2.8 (−0.8, 6.4) | 2.7 (−0.9, 6.3) |
| 226.8–327.6 | 494 | 398.8 (394.6, 403.0) | −1.1 (−4.0, 1.7) | −0.8 (−3.8, 2.3) | −0.4 (−3.6, 2.8) | −0.5 (−3.8, 2.7) |
| >327.6 | 553 | 399.0 (395.1, 403.0) | 0.8 (−2.5, 4.1) | 0.9 (−2.3, 4.2) | 1.7 (−1.9, 5.2) | 1.5 (−2.1, 5.2) |
| p-trend | 0.00 | 0.99 | 0.89 | 0.63 | 0.69 | |
| Secondhand smoking (SHS) | ||||||
| SHS unexposed never smokers | 688 | 410.5 (406.1, 414.9) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) |
| SHS exposed never smokers | 2418 | 407.1 (405.6, 408.6) | 0.5 (−2.4, 3.3) | 0.2 (−2.6, 2.9) | 0.9 (−2.0, 3.8) | 0.9 (−2.0, 3.8) |
| Current smokers | 2242 | 402.1 (400.0, 404.3) | 1.1 (−1.8, 4.1) | 1.1 (−1.8, 4.0) | 2.2 (−0.9, 5.2) | 2.0 (−1.0, 5.1) |
| p-value (SHS exposed vs.SHS unexposed never smokers) | 0.12 | 0.74 | 0.91 | 0.56 | 0.55 | |
| p-value (Current smokers vs. SHS unexposed never smoker) | <0.001 | 0.45 | 0.46 | 0.17 | 0.20 | |
a. Adjusted for age (continuous), race-ethnicity (non-Hispanic white, non-Hispanic black, Mexican-American, other), sex, and RR-interval (restricted quadratic splines with knots at the 5th, 50th, and 95th percentiles).
b. Further adjusted for BMI (continuous), high school education (yes, no), annual household income (<$20,000, ≥$20,000), and use of QT-prolonging medications (yes, no).
c. Further adjusted for systolic blood pressure, blood pressure lowering medication, total and HDL cholesterol, diabetes, history of myocardial infarction, history of congestive heart failure, serum potassium (continuous), and serum calcium (continuous).
d. Further adjusted for coffee (continuous), tea (continuous), number of drinks (continuous), and total physical activity (continuous).
The average difference in QT interval duration comparing participants drinking ≥7 drinks/week to non-drinkers in fully adjusted models was 1.8 ms (−0.5 to 4.0) (Table 4). After adjusting for age, race/ethnicity, sex and RR-interval, the average differences in QT interval duration comparing binge drinking to non-drinkers or to drinkers without binge drinking were 2.2 (0.1 to 4.4) and 3.1 ms (0.8 to 5.3), respectively. In the sex-stratified analysis, the average differences in QT interval comparing binge drinking to non-drinkers or drinkers without binge drinking were 2.8 (0.4 to 5.3) and 4.0 ms (1.6 to 6.4), respectively, among men, and 1.1 ms (−2.9 to 5.2) and 1.7 ms (−2.3 to 5.7), respectively, among women (Table S2). The interaction term for sex and binge drinking was not significant (p-value 0.34), although this analysis was limited by the relatively small number of women with binge drinking (282 women vs. 1005 men).
Table 4. Adjusted difference (95%CI) in QT interval duration by categories of alcohol consumption.
| N | Mean QT | Model 1 a | Model 2 b | Model 3 c | Model 4 d , e | |
| Alcohol (drinks/week) | ||||||
| 0 | 4513 | 406.0 (404.5, 407.5) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) |
| 1–3 | 2143 | 405.7 (404.0, 407.4) | −0.3 (−1.9, 1.2) | −0.2 (−1.8, 1.4) | −0.4 (−2.0, 1.3) | −0.5 (−2.1, 1.2) |
| 4–6 | 340 | 406.8 (402.5, 411.0) | 0.0 (−2.9, 2.9) | 0.6 (−2.3, 3.6) | 0.3 (−2.6, 3.1) | 0.2 (−2.7, 3.1) |
| ≥7 | 799 | 407.4 (403.2, 411.6) | 1.7 (−0.5, 3.8) | 2.7 (0.4, 4.9) | 1.9 (−0.3, 4.1) | 1.8 (−0.5, 4.0) |
| p-trend | 0.45 | 0.14 | 0.02 | 0.09 | 0.11 | |
| Binge drinking | ||||||
| Non-drinker or ex-drinker | 4623 | 406.0 (404.4, 407.6) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) |
| Current drinker, binge drinking | 1287 | 403.5 (400.6, 406.4) | 2.2 (0.1, 4.4) f | 2.4 (0.3, 4.5) f | 1.9 (−0.1, 3.9) f | 1.6 (−0.6, 3.7) f |
| p-value f | 0.14 | 0.05 | 0.03 | 0.07 | 0.16 | |
| Current drinker, no binge drinking | 1631 | 408.2 (406.2, 410.1) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) |
| Current drinker, binge drinking | 1287 | 403.5 (400.6, 406.4) | 3.1 (0.8, 5.3) g | 2.7 (0.5, 5.0) g | 2.2 (−0.1, 4.6) g | 2.1 (−0.4, 4.5) g |
| p-value g | 0.01 | 0.01 | 0.02 | 0.07 | 0.10 |
a. Adjusted for age (continuous), race-ethnicity (non-Hispanic white, non-Hispanic black, Mexican-American, other), sex, and RR-interval (restricted quadratic splines with knots at the 5th, 50th, and 95th percentiles).
b. Further adjusted for BMI (continuous), high school education (yes, no), annual household income (<$20,000, ≥$20,000), and use of QT-prolonging medications (yes, no).
c. Further adjusted for systolic blood pressure, blood pressure lowering medication, total and HDL cholesterol, diabetes, history of myocardial infarction, history of congestive heart failure, serum potassium (continuous), and serum calcium (continuous).
d. Further adjusted for coffee (continuous), tea (continuous), smoking (current, former, never), and total physical activity (continuous).
e. Model 4 for binge drinking further adjusted for number of drinks (continuous).
f. Current drinker, binge drinking vs. non-drinker or ex- drinker.
g. Current drinker, binge drinking vs. current drinker, no binge drinking.
Finally, the average differences in QT interval comparing the highest vs. the lowest categories of total and vigorous physical activity in the fully adjusted model were −0.8 (−3.0 to 1.4) and −0.3 ms (−2.9 to 2.4), respectively (Table 5). When stratified by sex, there was a trend towards shorter QT intervals with increasing levels of total activity in women but not in men in the fully adjusted model (p-trend 0.83 in men and 0.03 in women; p-interaction 0.09, Table S2).
Table 5. Adjusted difference (95%CI) in QT interval duration by categories of physical activity.
| N | Mean QT | Model 1 a | Model 2 b | Model 3 c | Model 4 d | |
| Total physical activity (times/week) | ||||||
| 0 | 2540 | 402.8 (400.3, 405.2) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) |
| 0.1–2.9 | 2918 | 405.1 (403.6, 406.6) | −0.3 (−2.1, 1.5) | 0.2 (−1.6, 2.0) | 0.4 (−1.3, 2.2) | 0.5 (−1.3, 2.2) |
| 3.0–7.9 | 1524 | 408.7 (406.8, 410.6) | −1.0 (−3.1, 1.0) | −0.4 (−2.4, 1.6) | −0.7 (−2.7, 1.2) | −0.7 (−2.7, 1.3) |
| ≥8.0 | 813 | 410.6 (407.4, 413.8) | −2.2 (−4.1, −0.2) | −1.0 (−3.0, 1.0) | −0.9 (−3.0, 1.3) | −0.8 (−3.0, 1.4) |
| p-trend | <0.001 | 0.03 | 0.23 | 0.20 | 0.20 | |
| Vigorous physical activity (times/week) | ||||||
| 0 | 5103 | 403.4 (402.1, 404.8) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) | 0.0 (reference) |
| 0.1–1.0 | 881 | 405.8 (403.3, 408.4) | −1.6 (−3.3, 0.1) | −1.1 (−2.9, 0.7) | −0.6 (−2.5, 1.3) | −0.6 (−2.5, 1.3) |
| 1.1–4.0 | 819 | 411.2 (408.5, 413.8) | −0.7 (−2.7, 1.3) | −0.3 (−2.3, 1.8) | −0.3 (−2.5, 1.9) | −0.2 (−2.5, 2.0) |
| >4 | 992 | 414.7 (410.9, 418.5) | −0.9 (−3.1, 1.4) | 0.0 (−2.4, 2.3) | −0.3 (−2.9, 2.3) | −0.3 (−2.9, 2.4) |
| p-trend | <0.001 | 0.52 | 0.95 | 0.83 | 0.88 | |
a. Adjusted for age (continuous), race-ethnicity (non-Hispanic white, non-Hispanic black, Mexican-American, other), sex, and RR-interval (restricted quadratic splines with knots at the 5th, 50th, and 95th percentiles).
b. Further adjusted for BMI (continuous), high school education (yes, no), annual household income (<$20,000, ≥$20,000), and use of QT-prolonging medications (yes, no).
c. Further adjusted for systolic blood pressure, blood pressure lowering medication, total and HDL cholesterol, diabetes, history of myocardial infarction, history of congestive heart failure, serum potassium (continuous), and serum calcium (continuous).
d. Further adjusted for coffee (continuous), tea (continuous), smoking (current, former, never), and number of drinks (continuous).
Discussion
In a large sample representative of the general US population, we found no association between QT interval duration and coffee or tea intake, cigarette smoking, physical activity, or total alcohol intake, although binge drinking was associated with an increased QT duration particularly in men.
Coffee, tea, and caffeine
Few studies have evaluated the effect of coffee or tea intake on the QT interval, although a few small studies have assessed the short-term effect of caffeine on cardiac repolarization. A study of 18 healthy subjects and 18 patients with frequent ventricular ectopic beats reported no significant change in QT interval in either group after caffeine ingestion (multiple doses of 1 mg/kg of body weight at intervals of one half-life during waking hours) [34]. Another study of 10 healthy volunteers showed that caffeine consumption (400 mg/day, equivalent of 4 cups of coffee) did not affect the QT interval [22]. In addition, experiments with canine ventricular muscle models found no effect of caffeine on cardiac action potentials, which may explain its lack of effect on the QT interval [45]. Our results were consistent with previous research and further suggested that usual intake of caffeine-containing drinks does not affect QT interval duration.
Cigarette smoking
Previous studies have shown conflicting results regarding the influence of acute and chronic smoking on QT interval duration. Some studies have reported longer QT intervals in smokers compared to non-smokers [25], [27]–[28], [46], while others found no significant differences [47] or even shorter QT intervals [29]. Another study showed that smoking cessation reduced the QT interval [32]. Most of these studies had small sample sizes and used only univariate analysis without adjustment for confounders. Furthermore, in some studies the results were dependent on the choice of formula for heart rate correction [23]. Our analysis, with a much larger sample size and more detailed adjustment for potential confounders, suggest a lack of effect of chronic smoking on QT interval duration, although we cannot completely exclude an association between smoking history, reflected in pack-years of smoking, and an increase in QT interval duration.
Alcohol consumption
A substantial body of literature has identified a variety of ECG abnormalities, including prolonged QT interval, in chronic alcoholics or heavy drinkers. Abnormalities of electrolytes (hypomagnesemia, hypopotassemia) [48]–[50], increased sympathetic tone and catecholamine secretion [51], as well as cardiac cellular infiltrate, hypertrophy, and fibrosis [52]–[53] are frequently seen in chronic alcoholism, which may all cause changes in QT interval. Electromechanical experiments also suggested a concentration-dependent effect of alcohol on action potential duration, with a decreased duration of repolarization at very high concentrations of alcohol but no effect at low concentrations [54]. Several studies of chronic alcoholics have reported either high incidences of prolonged QT (QTc>440 ms) [30]–[31], or longer QT intervals compared to normal controls [24], [26]. In addition, prolongation of the QT interval has also been reported after acute alcohol infusion [33]. In the present analysis, binge drinking, defined as five or more alcoholic drinks in one day during the past 12 months, may identify individuals with excessive heavy alcohol use and who were more likely to have chronic alcoholism. Our results suggested that binge drinking may prolong the QT interval compared to non-drinkers or drinkers without binge drinking, particularly in men. Compared to chronic alcoholism, less is known about the effect of social drinking on QT interval duration in the general population. The only population-based study we could identify (2,894 healthy men and women) showed no association between alcohol intake and QT duration [27]. Our data confirmed this observation that usual alcohol consumption was not associated with QT interval duration.
Physical activity
We did not find an association between physical activity and QT interval duration. When stratified by sex, the results suggested a trend towards shorter QT intervals with increasing levels of total activity in women but not in men. However, the test for interaction between sex and total physical activity was not significant, and a similar trend was not observed for vigorous physical activity. A previous study reported that high physical activity was associated with an increase in QT interval in men but not women [27]. It was hypothesized that a higher left ventricular mass could explain this association [27], and that this effect may only be observed at very high levels of physical activity. Differences in study population, levels of physical activity, and measurement of physical activity may explain the discrepancy with our findings.
Several limitations of our study need to be considered. First, all exposure factors and QT interval duration were measured at a single time at baseline, which may result in non-differential measurement error as there is substantial within person variability in all these variables. It is thus possible that our analysis may have missed some small associations between exposure factors and QT interval duration. Second, coffee, tea, alcohol, smoking and physical activity are associated with many other behaviors and cardiovascular risk factors, and we cannot exclude residual confounding. Third, the currenly analysis could not differentiate between the acute and long-term effect of each exposure factor due to the limited information available regarding duration and magnitude of exposure. Finally, QT interval duration is an intermediate physiological variable, and the impact of the observed changes on clinical cardiovascular events is uncertain. Some major strengths of this study are its large sample size, the careful standardization and detailed quality control procedures of NHANES, and the generalizability of the findings to the general US population.
In conclusion, data from NHANES III, a large sample representative of the general US population, found no association between QT interval duration and coffee or tea intake, smoking, physical activity and usual drinking, but suggested an association between binge drinking and longer QT interval in men. Future studies are needed to further elucidate the biological mechanisms underlying the observed association between binge drinking and QT interval duration and the role of heavy alcohol intake in QT abnormalities and arrhythmia triggering in the general population.
Supporting Information
Adjusted difference (95%CI) in Bazett’s equation-corrected QT (QTb) interval duration.
(DOC)
Adjusted difference (95%CI) in QT interval by sex.
(DOC)
Footnotes
Competing Interests: The authors have declared that no competing interests exist.
Funding: The present study was funded in part by grants from the National Center for Cardiovascular Research (CNIC Translational Cardiology grant 2008-03), the National Institutes of Health (grants ES015597 and HL091062), the Donald W. Reynolds Cardiovascular Clinical Research Center at Johns Hopkins University and the Fondation Leducq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.
References
- 1.Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, et al. Risk stratification in the long-QT syndrome. N Engl J Med. 2003;348:1866–1874. doi: 10.1056/NEJMoa022147. [DOI] [PubMed] [Google Scholar]
- 2.Sauer AJ, Moss AJ, McNitt S, Peterson DR, Zareba W, et al. Long QT syndrome in adults. J Am Coll Cardiol. 2007;49:329–337. doi: 10.1016/j.jacc.2006.08.057. [DOI] [PubMed] [Google Scholar]
- 3.Gaita F, Giustetto C, Bianchi F, Wolpert C, Schimpf R, et al. Short QT Syndrome: a familial cause of sudden death. Circulation. 2003;108:965–970. doi: 10.1161/01.CIR.0000085071.28695.C4. [DOI] [PubMed] [Google Scholar]
- 4.Gussak I, Brugada P, Brugada J, Wright RS, Kopecky SL, et al. Idiopathic short QT interval: a new clinical syndrome? Cardiology. 2000;94:99–102. doi: 10.1159/000047299. [DOI] [PubMed] [Google Scholar]
- 5.Schimpf R, Borggrefe M, Wolpert C. Clinical and molecular genetics of the short QT syndrome. Curr Opin Cardiol. 2008;23:192–198. doi: 10.1097/HCO.0b013e3282fbf756. [DOI] [PubMed] [Google Scholar]
- 6.Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. QT interval variables from 24 hour electrocardiography and the two year risk of sudden death. Br Heart J. 1993;70:43–48. doi: 10.1136/hrt.70.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Dekker JM, Schouten EG, Klootwijk P, Pool J, Kromhout D. Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study. Circulation. 1994;90:779–785. doi: 10.1161/01.cir.90.2.779. [DOI] [PubMed] [Google Scholar]
- 8.Dekker JM, Crow RS, Hannan PJ, Schouten EG, Folsom AR. Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: the ARIC study. J Am Coll Cardiol. 2004;43:565–571. doi: 10.1016/j.jacc.2003.09.040. [DOI] [PubMed] [Google Scholar]
- 9.Okin PM, Devereux RB, Howard BV, Fabsitz RR, Lee ET, et al. Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. Circulation. 2000;101:61–66. doi: 10.1161/01.cir.101.1.61. [DOI] [PubMed] [Google Scholar]
- 10.Pytlak A, Piotrowski W. Prognostic Significance of QTc Interval for prediction total, cardiac, and ischemic heart disease mortality in community-based cohort from Warsaw Pol-MONICA population. ANE. 2000;5:322–329. [Google Scholar]
- 11.Perkiomaki JS, Sourander LB, Levomaki L, Raiha IJ, Puukka P, et al. Qt dispersion and mortality in the elderly. Ann Noninvasive Electrocardiol. 2001;6:183–192. doi: 10.1111/j.1542-474x.2001.tb00106.x. [DOI] [PubMed] [Google Scholar]
- 12.Robbins J, Nelson JC, Rautaharju PM, Gottdiener JS. The association between the length of the QT interval and mortality in the Cardiovascular Health Study. Am J Med. 2003;115:689–694. doi: 10.1016/j.amjmed.2003.07.014. [DOI] [PubMed] [Google Scholar]
- 13.Sheehan J, Perry IJ, Reilly M, Salim A, Collins M, et al. QT dispersion, QT maximum and risk of cardiac death in the Caerphilly Heart Study. Eur J Cardiovasc Prev Rehabil. 2004;11:63–68. doi: 10.1097/01.hjr.0000114970.39211.9e. [DOI] [PubMed] [Google Scholar]
- 14.Nilsson G, Hedberg P, Jonasson T, Lonnberg I, Ohrvik J. QTc interval and survival in 75-year-old men and women from the general population. Europace. 2006;8:233–240. doi: 10.1093/europace/euj040. [DOI] [PubMed] [Google Scholar]
- 15.Rautaharju PM, Kooperberg C, Larson JC, LaCroix A. Electrocardiographic abnormalities that predict coronary heart disease events and mortality in postmenopausal women: the Women's Health Initiative. Circulation. 2006;113:473–480. doi: 10.1161/CIRCULATIONAHA.104.496091. [DOI] [PubMed] [Google Scholar]
- 16.Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47:362–367. doi: 10.1016/j.jacc.2005.08.067. [DOI] [PubMed] [Google Scholar]
- 17.Kao WH, Arking DE, Post W, Rea TD, Sotoodehnia N, et al. Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations. Circulation. 2009;119:940–951. doi: 10.1161/CIRCULATIONAHA.108.791723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Montanez A, Ruskin JN, Hebert PR, Lamas GA, Hennekens CH. Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies. Arch Intern Med. 2004;164:943–948. doi: 10.1001/archinte.164.9.943. [DOI] [PubMed] [Google Scholar]
- 19.Akylbekova EL, Crow RS, Johnson WD, Buxbaum SG, Njemanze S, et al. Clinical correlates and heritability of QT interval duration in blacks: the Jackson Heart Study. Circ Arrhythm Electrophysiol. 2009;2:427–432. doi: 10.1161/CIRCEP.109.858894. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Benoit SR, Mendelsohn AB, Nourjah P, Staffa JA, Graham DJ. Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey. Eur J Cardiovasc Prev Rehabil. 2005;12:363–368. doi: 10.1097/01.hjr.0000173110.21851.a9. [DOI] [PubMed] [Google Scholar]
- 21.Kobza R, Roos M, Niggli B, Abacherli R, Lupi GA, et al. Prevalence of long and short QT in a young population of 41,767 predominantly male Swiss conscripts. Heart Rhythm. 2009;6:652–657. doi: 10.1016/j.hrthm.2009.01.009. [DOI] [PubMed] [Google Scholar]
- 22.Ammar R, Song JC, Kluger J, White CM. Evaluation of electrocardiographic and hemodynamic effects of caffeine with acute dosing in healthy volunteers. Pharmacotherapy. 2001;21:437–442. doi: 10.1592/phco.21.5.437.34502. [DOI] [PubMed] [Google Scholar]
- 23.Andrassy G, Szabo A, Dunai A, Simon E, Nagy T, et al. Acute effects of cigarette smoking on the QT interval in healthy smokers. Am J Cardiol. 2003;92:489–492. doi: 10.1016/s0002-9149(03)00678-7. [DOI] [PubMed] [Google Scholar]
- 24.Day CP, James OF, Butler TJ, Campbell RW. QT prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet. 1993;341:1423–1428. doi: 10.1016/0140-6736(93)90879-l. [DOI] [PubMed] [Google Scholar]
- 25.Dilaveris P, Pantazis A, Gialafos E, Triposkiadis F, Gialafos J. The effects of cigarette smoking on the heterogeneity of ventricular repolarization. Am Heart J. 2001;142:833–837. doi: 10.1067/mhj.2001.118737. [DOI] [PubMed] [Google Scholar]
- 26.Ettinger PO, Wu CF, De La Cruz C, Jr, Weisse AB, Ahmed SS, et al. Arrhythmias and the "Holiday Heart": alcohol-associated cardiac rhythm disorders. Am Heart J. 1978;95:555–562. doi: 10.1016/0002-8703(78)90296-x. [DOI] [PubMed] [Google Scholar]
- 27.Fauchier L, Maison-Blanche P, Forhan A, D'Hour A, Lepinay P, et al. Association between heart rate-corrected QT interval and coronary risk factors in 2,894 healthy subjects (the DESIR Study). Data from an Epidemiological Study on the Insulin Resistance syndrome. Am J Cardiol. 2000;86:557–559, A559. doi: 10.1016/s0002-9149(00)01015-8. [DOI] [PubMed] [Google Scholar]
- 28.Ileri M, Yetkin E, Tandogan I, Hisar I, Atak R, et al. Effect of habitual smoking on QT interval duration and dispersion. Am J Cardiol. 2001;88:322–325. doi: 10.1016/s0002-9149(01)01653-8. [DOI] [PubMed] [Google Scholar]
- 29.Karjalainen J, Reunanen A, Ristola P, Viitasalo M. QT interval as a cardiac risk factor in a middle aged population. Heart. 1997;77:543–548. doi: 10.1136/hrt.77.6.543. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Kino M, Imamitchi H, Morigutchi M, Kawamura K, Takatsu T. Cardiovascular status in asymptomatic alcoholics, with reference to the level of ethanol consumption. Br Heart J. 1981;46:545–551. doi: 10.1136/hrt.46.5.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Koide T, Kato A, Takabatake Y, Iizuka M, Uchida Y, et al. Variable prognosis in congestive cardiomyopathy. Role of left ventricular function, alcoholism, and pulmonary thrombosis. Jpn Heart J. 1980;21:451–463. [PubMed] [Google Scholar]
- 32.Lewis MJ, Balaji G, Dixon H, Syed Y, Lewis KE. Influence of smoking abstinence and nicotine replacement therapy on heart rate and QT time-series. Clin Physiol Funct Imaging. 30:43–50. doi: 10.1111/j.1475-097X.2009.00902.x. [DOI] [PubMed] [Google Scholar]
- 33.Rossinen J, Sinisalo J, Partanen J, Nieminen MS, Viitasalo M. Effects of acute alcohol infusion on duration and dispersion of QT interval in male patients with coronary artery disease and in healthy controls. Clin Cardiol. 1999;22:591–594. doi: 10.1002/clc.4960220910. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Sutherland DJ, McPherson DD, Renton KW, Spencer CA, Montague TJ. The effect of caffeine on cardiac rate, rhythm, and ventricular repolarization. Analysis of 18 normal subjects and 18 patients with primary ventricular dysrhythmia. Chest. 1985;87:319–324. doi: 10.1378/chest.87.3.319. [DOI] [PubMed] [Google Scholar]
- 35.Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital Health Stat. 1994;1:1–407. [PubMed] [Google Scholar]
- 36.Drugs that Prolong the QT Interval and/or Induce Torsades de Pointes Ventricular Arrhythmia. http://wwwazcertorg/medical-pros/drug-lists/drug-listscfm (accessed 09/2009)
- 37.Salazar-Martinez E, Willett WC, Ascherio A, Manson JE, Leitzmann MF, et al. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med. 2004;140:1–8. doi: 10.7326/0003-4819-140-1-200401060-00005. [DOI] [PubMed] [Google Scholar]
- 38.Choi HK, Curhan G. Coffee, tea, and caffeine consumption and serum uric acid level: the third national health and nutrition examination survey. Arthritis Rheum. 2007;57:816–821. doi: 10.1002/art.22762. [DOI] [PubMed] [Google Scholar]
- 39.Bernert JT, Jr, Turner WE, Pirkle JL, Sosnoff CS, Akins JR, et al. Development and validation of sensitive method for determination of serum cotinine in smokers and nonsmokers by liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Clin Chem. 1997;43:2281–2291. [PubMed] [Google Scholar]
- 40.CDC. Fouth National Report on Human Exposure to Environmental Chemicals. 2010. http://www.cdc.gov/exposurereport/ (Accessed October 25, 2010)
- 41.Shiels MS, Rohrmann S, Menke A, Selvin E, Crespo CJ, et al. Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men. Cancer Causes Control. 2009;20:877–886. doi: 10.1007/s10552-009-9318-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Agarwal S. The association of active and passive smoking with peripheral arterial disease: results from NHANES 1999-2004. Angiology. 2009;60:335–345. doi: 10.1177/0003319708330526. [DOI] [PubMed] [Google Scholar]
- 43.Ainsworth BE, Haskell WL, Leon AS, Jacobs DR, Jr, Montoye HJ, et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc. 1993;25:71–80. doi: 10.1249/00005768-199301000-00011. [DOI] [PubMed] [Google Scholar]
- 44.Rautaharju PM, MacInnis PJ, Warren JW, Wolf HK, Rykers PM, et al. Methodology of ECG interpretation in the Dalhousie program; NOVACODE ECG classification procedures for clinical trials and population health surveys. Methods Inf Med. 1990;29:362–374. [PubMed] [Google Scholar]
- 45.Linuma H, Kato K. The effects of extracellular potassium and several drugs on the premature action potential and postextrasystolic potentiation. Eur J Cardiol. 1978;7:465–477. [PubMed] [Google Scholar]
- 46.Singh K. Effect of smoking on QT interval, QT dispersion and rate pressure product. Indian Heart J. 2004;56:140–142. [PubMed] [Google Scholar]
- 47.Romero Mestre JC, Licea Puig M, Faget Cepero O, Perich Amador P, Marquez-Guillen A. [Studies of cardiovascular autonomic function and duration of QTc interval in smokers]. Rev Esp Cardiol. 1996;49:259–263. [PubMed] [Google Scholar]
- 48.Fankushen D, Raskin D, Dimich A, Wallach S. The Significance of Hypomagnesemia in Alcoholic Patients. Am J Med. 1964;37:802–812. doi: 10.1016/0002-9343(64)90028-2. [DOI] [PubMed] [Google Scholar]
- 49.Lim P, Jacob E. Magnesium status of alcoholic patients. Metabolism. 1972;21:1045–1051. doi: 10.1016/0026-0495(72)90035-2. [DOI] [PubMed] [Google Scholar]
- 50.Vetter WR, Cohn LH, Reichgott M. Hypokalemia and electrocardiographic abnormalities during acute alcohol withdrawal. Arch Intern Med. 1967;120:536–541. [PubMed] [Google Scholar]
- 51.Giacobini E, Izikowitz S, Wegmann A. The urinary excretion of noradrenaline and adrenaline during acute alcohol intoxication in alcoholic addicts. Experientia. 1960;16:467. doi: 10.1007/BF02171159. [DOI] [PubMed] [Google Scholar]
- 52.Schenk EA, Cohen J. The heart in chronic alcoholism. Clinical and pathologic findings. Pathol Microbiol (Basel) 1970;35:96–104. doi: 10.1159/000162206. [DOI] [PubMed] [Google Scholar]
- 53.Hognestad J, Teisberg P. Heart pathology in chronic alcoholism. Acta Pathol Microbiol Scand A. 1973;81:315–322. doi: 10.1111/j.1699-0463.1973.tb03540.x. [DOI] [PubMed] [Google Scholar]
- 54.Tsai CS, Loh SH, Jin JS, Hong GJ, Lin HT, et al. Effects of alcohol on intracellular pH regulators and electromechanical parameters in human myocardium. Alcohol Clin Exp Res. 2005;29:1787–1795. doi: 10.1097/01.alc.0000183512.31705.74. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Adjusted difference (95%CI) in Bazett’s equation-corrected QT (QTb) interval duration.
(DOC)
Adjusted difference (95%CI) in QT interval by sex.
(DOC)